Press Releases

Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19. The investigational medicine, referred to as JS016, is being co-developed by Junshi...

FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a leading contract development and manufacturing organization (CDMO) for biologics and advanced therapies. The capital...

Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19. The Company received approval from the Drugs Controller General of India (DCGI) for conducting Phase...

Marken announced it has begun producing COVID-19 test kits in its Miami facility as an extension of its global supply chain solutions offering. The completed kits are currently shipping and will be distributed throughout the U.S. and Canada. As one...

Thermo Fisher Scientific announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing agreement. The CDx will leverage the Oncomine Precision Assay, which...

Sharp Clinical Services, part of UDG Healthcare and a leading provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support programme with its sister company, Ashfield. The company has signed a...

AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the...